Trastuzumab in HER2-Positive Uterine Serous Carcinoma (Fader) Last updated on Jun 5, 2026 Previous ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer Next Publications Update # 142
